BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37024907)

  • 1. Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.
    Pei J; Su Z; Zeng X; Zhong Y; Zhang Y; Yang Y; Lu Q; Li J; Deng Y
    BMC Complement Med Ther; 2023 Apr; 23(1):111. PubMed ID: 37024907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma.
    Ma S; Egyházi S; Ueno T; Lindholm C; Kreklau EL; Stierner U; Ringborg U; Hansson J
    Br J Cancer; 2003 Oct; 89(8):1517-23. PubMed ID: 14562026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of O(6)-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy.
    Ma S; Egyházi S; Martenhed G; Ringborg U; Hansson J
    Melanoma Res; 2002 Aug; 12(4):335-42. PubMed ID: 12170182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.
    Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S
    Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.
    Busch C; Geisler J; Lillehaug JR; Lønning PE
    Eur J Cancer; 2010 Jul; 46(11):2127-33. PubMed ID: 20541396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
    Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
    Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
    Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X
    Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy.
    Ma S; Egyházi S; Ringborg U; Hansson J
    Oncol Rep; 2002; 9(5):1015-9. PubMed ID: 12168066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.
    Naumann SC; Roos WP; Jöst E; Belohlavek C; Lennerz V; Schmidt CW; Christmann M; Kaina B
    Br J Cancer; 2009 Jan; 100(2):322-33. PubMed ID: 19127257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
    Philip PA; Souliotis VL; Harris AL; Salisbury A; Tates AD; Mitchell K; van Delft JH; Ganesan TS; Kyrtopoulos SA
    Clin Cancer Res; 1996 Feb; 2(2):303-10. PubMed ID: 9816173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine.
    Thangasamy T; Sittadjody S; Limesand KH; Burd R
    Cell Oncol; 2008; 30(5):371-87. PubMed ID: 18791269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma.
    Kiyohara E; Tamai K; Katayama I; Kaneda Y
    Gene Ther; 2012 Jul; 19(7):734-41. PubMed ID: 21900962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.
    Zheng M; Bocangel D; Ramesh R; Ekmekcioglu S; Poindexter N; Grimm EA; Chada S
    Mol Cancer Ther; 2008 Dec; 7(12):3842-51. PubMed ID: 19056673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.
    Singh S; Davis R; Alamanda V; Pireddu R; Pernazza D; Sebti S; Lawrence N; Chellappan S
    Mol Cancer Ther; 2010 Dec; 9(12):3330-41. PubMed ID: 21139044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of DNA repair host factors on temozolomide or dacarbazine melanoma treatment in Caucasians.
    Boeckmann L; Schirmer M; Rosenberger A; Struever D; Thoms KM; Gutzmer R; Has C; Kunz M; Kuschal C; Laspe P; Schoen MP; Brockmoeller J; Emmert S
    Pharmacogenet Genomics; 2009 Oct; 19(10):760-9. PubMed ID: 19741564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
    Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
    Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment.
    Li X; Yang C; Luo N; Yang Y; Guo Y; Chen P; Cun B
    Cancer Biomark; 2022; 34(2):275-284. PubMed ID: 34958003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma.
    Yang C; Cao H; Liu N; Xu K; Ding M; Mao LJ
    Drug Des Devel Ther; 2016; 10():3755-3761. PubMed ID: 27895465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
    Thallinger C; Werzowa J; Poeppl W; Kovar FM; Pratscher B; Valent P; Quehenberger P; Joukhadar C
    J Invest Dermatol; 2007 Oct; 127(10):2411-7. PubMed ID: 17508024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells.
    Biteghe FN; Davids LM
    J Photochem Photobiol B; 2017 Jan; 166():18-27. PubMed ID: 27852006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.